Stay updated on Nivolumab in Type B3 Thymoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Type B3 Thymoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer site revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T20:19:41.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T20:37:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the former study details and navigation with an error screen. This prevents users from viewing or interacting with the study record as intended.
    Difference
    18%
    Check dated 2026-09-19T20:39:56.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added the NIH grant/contract identifier '2015 ( U.S. NIH Grant/Contract )' to the study's identifiers. Updated the page revision to v3.6.6, replacing v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:02:03.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page shows a new revision label, v3.6.5, replacing the previous v3.6.4. This reflects a minor update or re-release of the page content.
    Difference
    0.0%
    Check dated 2026-08-08T20:02:46.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision label on the page was updated to v3.6.4, replacing the previous v3.6.3 as part of a small software update.
    Difference
    0.0%
    Check dated 2026-07-25T12:37:10.000Z thumbnail image

Stay in the know with updates to Nivolumab in Type B3 Thymoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.